Médunik Canada is dedicated to developing strong partnerships with non-Canadian pharmaceutical and biopharmaceutical companies that are attempting to optimize the return on investment of their orphan drugs; they need to balance the financial risks and complexities associated to the introduction and distribution of their products on the small-size Canadian market. Through in-licensing partnerships, Médunik Canada offers turn-key operations – ranging from regulatory approval strategy to post-approval activities – to assure the commercial success of the partners’ product development efforts.
950, boul. Michèle-Bohec
Blainville (Québec) Canada
Tel.: + 1 450 433-4441
Fax: + 1 450 433-2211
Gary Goodyear, Minister for Science, shares with us how the Canadian Government has taken a different approach to…